INSIDE BUSINESS AFRICA DECEMBER EDITION | Page 26

I N S I D E B U S I N E S S A F R I C A
THE MAGAZINE 0F THE CORPORATE WORLD
Health Treport
Abubaka Malami SAN
SOURCE : THE AFRICAN REPORT

South Africa ' s pharmaceutical regulator SAHPRA said on Monday it has received its first application to register a Covid-19 vaccine from J o h n s o n & Johnson . " As of today we have received one application , this was received on T h u r s d a y evening from J & J , a n d w e started the review process ," said B o i t u m e l o Semete , chief executive of the South African Health Products Regulatory Authority .

�A2 �
�A3 � D E C E M B E R 2 0 2 0 D E C E M B E R 2 0 2 0
J & J did not immediately respond to an emailed request for comment . The US firm ' s vaccine candidate is one of at least four Covid vaccines being trialled in South Africa , along with candidates being developed by Novavax , AstraZeneca and Pfizer .
Semete told a news conference the regulator would focus on " safety , quality and efficacy " of any coronavirus vaccine used in the country of around 58-million as it fast-tracks vaccine approvals .
South Africa , which officially entered a second wave of infections last week , has more than 860 000 infections and 23 000 deaths , and is the worst-hit country in the continent